ESG

BNY Mellon's steady dividend offers a window into the high-yield debt market, a crucial, high-risk funding source for the mining sector's energy transition.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A new report shows a startling drop in dental benefits, revealing deep cracks in America's health system and new economic pressures on employers.

A new platform lets your idle devices earn Bitcoin. Is this a futuristic lifestyle trend for luxury living or just a volatile digital experiment?

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

Hyatt's new safari partnership isn't just a perk; it's a strategic move into purpose-driven travel, redefining luxury loyalty for a new era.

OTC-listed Lelantos Holdings, known for renewables, bets its future on a historic Arizona gold-copper mine. A strategic pivot or a high-stakes gamble?

An Auckland firm is using Meta Smart Glasses for pest inspections, giving clients an unprecedented look inside their walls and setting a new standard for transparency.

A strategic investment firm's move signals strong confidence in the closing of Avadel's multi-billion dollar deal, spotlighting its blockbuster sleep drug.

A Chinese firm's entry into Germany's EV market seems distant from medicine, but its tricycle vehicle could be the key to a greener, faster last-mile for healthcare.

Trinity Consultants' acquisition of CEQA/NEPA expert Meridian is more than a regional deal; it's a strategic move with deep implications for biopharma.

As homelessness surges, a tech-powered partnership doubles its mobile clinic fleet, deploying a new, strategic model for healthcare and social integration.

A new oral drug could eliminate the dangerous side effects of CAR T-Cell therapy, potentially making the breakthrough cancer treatment safer and more accessible.

A new star-studded series celebrates Shenzhen's rise. Beyond the screen, it reveals a carefully crafted blueprint for national branding and economic ambition.

Allbirds co-founder Joey Zwillinger is applying consumer tech disruption to women's health. Can Biologica's science-backed model reshape a stagnant market?